Rheo-Erythrocrine Dysfunction as a Biomarker for RIC Treatment in Acute Ischemic Stroke
Condition(s):Stroke, Acute; Ischemic Stroke; Cerebrovascular Disorders; Central Nervous System DiseasesLast Updated:January 15, 2021Recruiting
Hide Studies Not Open or Pending
Condition(s):Stroke, Acute; Ischemic Stroke; Cerebrovascular Disorders; Central Nervous System DiseasesLast Updated:January 15, 2021Recruiting
Condition(s):Liver Failure; Carcinoma, HepatocellularLast Updated:August 20, 2019Completed
Condition(s):Ischemic Reperfusion InjuryLast Updated:August 31, 2018Unknown status
Condition(s):Ischemic Reperfusion InjuryLast Updated:August 31, 2018Unknown status
Condition(s):Myocardial Ischemic Reperfusion Injury; End Stage Heart Disease; Heart Failure; CardiomyopathyLast Updated:December 23, 2016Completed
Condition(s):Moyamoya Disease; Remote Ischemic PreconditioningLast Updated:August 23, 2018Completed
Condition(s):Ischemia Reperfusion InjuryLast Updated:September 26, 2007Unknown status
Condition(s):HepatectomyLast Updated:July 19, 2011Completed
Condition(s):ST-elevation Myocardial InfarctionLast Updated:June 26, 2018Completed
Condition(s):Coronary Artery Disease; Myocardial InfarctionLast Updated:February 9, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.